| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/16/2014 | CA2677842C Pharmaceutical composition comprising microparticle oily suspension |
| 09/16/2014 | CA2596235C Spiroketal derivatives and use thereof as diabetic medicine |
| 09/12/2014 | WO2014136814A1 Novel peptide having 5 linked ctl epitopes |
| 09/12/2014 | WO2014136808A1 Cell-death inhibitor, and production method therefor |
| 09/12/2014 | WO2014136807A1 Cell-death inhibitor, and novel compound |
| 09/12/2014 | WO2014136672A1 Ectoparasite control agent |
| 09/12/2014 | WO2014136161A1 Osteopontin production inhibitor comprising dictyopyrone derivative or dihydrodictyopyrone derivative as active ingredient |
| 09/11/2014 | US20140256743 Cathepsin cysteine protease inhibitors |
| 09/11/2014 | US20140256652 Polypeptides Involved In Immune Response |
| 09/11/2014 | US20140255493 Extrudate and methods of using said extrudate |
| 09/10/2014 | EP2774932A1 Novel compound contained in manuka honey and use of same |
| 09/10/2014 | EP2774926A1 Morphinan derivative |
| 09/10/2014 | EP2774917A1 Pharmaceutical composition for treating diabetes |
| 09/10/2014 | EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 09/10/2014 | EP2773364A1 Stable pharmaceutical formulations of growth factor peptides |
| 09/09/2014 | US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA |
| 09/09/2014 | US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor |
| 09/09/2014 | US8828443 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 09/09/2014 | US8828381 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
| 09/04/2014 | WO2014134510A1 Glycopyrrolate salts |
| 09/04/2014 | WO2014134380A1 Administration of gamma hydroxybutyrate with monocarboxylate transporters |
| 09/04/2014 | WO2014132671A1 Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent |
| 09/04/2014 | WO2014131865A1 Therapeutic agent for amniotic fluid embolism |
| 09/04/2014 | US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 09/04/2014 | US20140248609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/03/2014 | EP2772490A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
| 09/03/2014 | EP2772485A1 Bicyclic compound |
| 09/03/2014 | EP2772263A1 Enhanced anabolic cytokine production and delivery system |
| 09/02/2014 | US8822685 2,4-pyrimidinediamine compounds and their uses |
| 09/02/2014 | US8822636 Peptides for activation and inhibition of δPKC |
| 09/02/2014 | US8822458 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/02/2014 | US8822169 HMG1 antibody for treating inflammatory conditions |
| 09/02/2014 | CA2645488C Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| 08/28/2014 | WO2014130723A1 Methods and compositions for treatment of pompe disease |
| 08/28/2014 | WO2014130722A1 Methods and compositions for treatment of forbes-cori disease |
| 08/28/2014 | US20140243284 Biologically active macrolides, compositions, and uses thereof |
| 08/28/2014 | US20140242094 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 08/28/2014 | US20140242089 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 08/28/2014 | US20140242086 Polynucleotides encoding signal peptide-containing molecules |
| 08/27/2014 | EP2769980A1 Pyrazoloquinoline derivative |
| 08/27/2014 | EP2769718A1 Medicinal composition |
| 08/27/2014 | EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto |
| 08/26/2014 | US8815821 Double-stranded oligonucleotides |
| 08/26/2014 | US8815803 Method for increasing body height comprising systemic administration of CNP-53 |
| 08/26/2014 | US8815801 Controlled release composition and method of producing the same |
| 08/26/2014 | US8815287 Opiod agonist formulations with releasable and sequestered antagonist |
| 08/26/2014 | US8815270 Methods and compositions for treating ectoparasite infestation |
| 08/21/2014 | WO2014125013A1 D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response |
| 08/21/2014 | US20140235564 Methods for treating neural cell swelling |
| 08/21/2014 | DE50103551C5 Neue tiotropium-haltige inhalationspulver New tiotropium-containing inhalation powder |
| 08/20/2014 | EP2767539A1 Pseudopolymorphic forms of a HIV protease inhibitor |
| 08/20/2014 | EP2767310A1 Methods Of Reduction Of Interpatient Variability |
| 08/20/2014 | EP2767284A1 D-Fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response |
| 08/20/2014 | EP2767280A1 Anemia of cancer improving / prophylactic agent |
| 08/20/2014 | EP2767279A1 Erythropoietin production-promoting agent |
| 08/20/2014 | EP2767277A1 Treatment agent and/or prophylactic agent for side effects of cancer drugs |
| 08/20/2014 | EP2767276A1 Improving / prophylactic agent for chronic kidney disease |
| 08/20/2014 | EP2766356A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof |
| 08/20/2014 | EP2766042A1 ANTIBODIES TO CD1d |
| 08/19/2014 | US8809281 Small peptides and methods for blocking IGE mediated activation of an immune cell |
| 08/19/2014 | CA2545435C Hydroxy piperidine derivatives to treat gaucher disease |
| 08/19/2014 | CA2488057C Hair follicle mesenchymal stem cells and use thereof |
| 08/19/2014 | CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use |
| 08/19/2014 | CA2411596C Therapeutic agents - ii |
| 08/19/2014 | CA2334872C Use of exendin-4 to treat impaired glucose tolerance |
| 08/14/2014 | WO2013185112A8 Pharmaceutical compositions for the treatment of cftr -mediated disorders |
| 08/14/2014 | US20140227275 Methods of treating and diagnosing pancreatitis |
| 08/14/2014 | US20140227194 Preparation for Restenosis Prevention |
| 08/14/2014 | US20140227193 Preparation for Restenosis Prevention |
| 08/14/2014 | US20140227192 Preparation for Restenosis Prevention |
| 08/13/2014 | EP2764864A1 Novel anti-hcv agent |
| 08/13/2014 | EP2764863A1 Tau aggregation inhibitor |
| 08/13/2014 | EP2763684A1 Composition for the treatment of fistula |
| 08/13/2014 | EP2763650A2 Compositions for enhancing nail health |
| 08/13/2014 | CN103987706A 吡啶酮衍生物以及含有吡啶酮衍生物的药物 Pyridinone derivatives, and the drug-containing pyridone derivatives |
| 08/13/2014 | CN103987386A 具有有相称效果的调节活性的(rs)-2-(2-氧代-4-苯基吡咯烷-1-基)乙酰胺化合物、药物物质(变体)及其应用、其组合物(变体) With a commensurate effect modulating activity (rs) -2- (2- oxo-4-phenyl-pyrrolidin-1-yl) acetamide compound, a drug substance (variants) and its application, the composition (varying body) |
| 08/13/2014 | CN103977285A 一种治疗自汗、盗汗的中药 A treatment for spontaneous, night sweats medicine |
| 08/13/2014 | CN103977000A 索拉非尼在制备药物中的应用 Sorafenib in the manufacture of a medicament |
| 08/13/2014 | CN103976952A 一种Alda-1口服自微乳制剂及其制备方法 One kind of Alda-1 oral microemulsion formulation since its preparation method |
| 08/13/2014 | CN103080085B 4,4'-[4-氟-7-({4-[4-(3-氟-2-甲基苯基)丁氧基]苯基}乙炔基)-2-甲基-1h-吲哚-1,3-二基]二丁酸的新晶型 4,4 '- [4-fluoro-7 - ({4- [4- (3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl) -2-methyl-indazol -1h- indole-1,3-diyl] bis butanoic acid new polymorphs |
| 08/13/2014 | CN102883733B Age生成抑制剂 Age generation inhibitors |
| 08/13/2014 | CN102464718B 人源化之单克隆抗体、其氨基酸序列与核苷酸序列与其用途 A humanized monoclonal antibody, the amino acid sequence of the nucleotide sequence and its use |
| 08/13/2014 | CN101747354B 一类β氨基酸组成的二肽硼酸及其酯类化合物、制备方法及其用途 Dipeptide boronic acid and its esters for a class of β amino acid composition, preparation and uses |
| 08/12/2014 | US8802717 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 08/12/2014 | US8802699 Quinuclidine derivatives and medicinal compositions containing the same |
| 08/12/2014 | US8802164 Method for promoting carnitine palmitoyltransferase activity using green coffee bean extract |
| 08/12/2014 | US8802125 Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof |
| 08/12/2014 | CA2683941C Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 08/12/2014 | CA2621310C Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 08/07/2014 | US20140221497 Methods of Using Rapid-Onset Selective Serotonin Reuptake Inhibitors for Treating Sexual Dysfunction |
| 08/07/2014 | US20140221405 Platelet adp receptor inhibitors |
| 08/07/2014 | US20140221381 Thienopyrimidine compounds and use thereof |
| 08/07/2014 | US20140219991 Treatment and composition for wound healing |
| 08/06/2014 | EP2762489A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 08/06/2014 | EP2762476A1 1,2,4-triazine-6-carboxamide derivative |
| 08/06/2014 | EP2762466A1 Phenyl derivative |
| 08/06/2014 | EP2762148A1 Novel phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition |
| 08/06/2014 | EP2762144A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 08/06/2014 | EP2762141A1 Drug for the treatment of allergic rhinitis comprising pgd2 antagonist and histamine antagonist |
| 08/06/2014 | EP2762138A1 Pharmaceutical substance (variants) and compositions based thereon which exhibit modulatory activity with a commensurate effect |